The aim of the study is to evaluate the effectiveness and the safety of the EYEOP treatment using High Intensity Focused Ultrasound in refractory glaucoma patients.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
52
Cyclocoagulation using High Intensity Focused Ultrasound with EYEOP device
University Hospital
Dijon, France
University Hospital
Grenoble, France
University Hospital - Cl Huriez
Lille, France
Clinique du Parc - Private Hospital
Lyon, France
Primary efficacy measure :
IOP change (mmHg and Percent) from baseline to 6 months post-HIFU treatment
Time frame: 6 months
Safety measures
The incidence of device and procedure-related complications during the follow-up
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Croix Rousse Hospital
Lyon, France
XV-XX National Ophthalmologic Hospital
Paris, France
XV-XX Ophthalmologic Hospital
Paris, France
Saint-Joseph Hospital
Paris, France
Val de Grace Hospital
Paris, France